Logo image of GKO.CA

GEEKCO TECHNOLOGIES CORP (GKO.CA) Stock Fundamental Analysis

TSX-V:GKO - TSX Venture Exchange - CA36847L1040 - Common Stock - Currency: CAD

0.035  -0.02 (-36.36%)

Fundamental Rating

0

Overall GKO gets a fundamental rating of 0 out of 10. We evaluated GKO against 0 industry peers in the Unkown industry. GKO has a bad profitability rating. Also its financial health evaluation is rather negative. GKO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

GKO had negative earnings in the past year.
In the past 5 years GKO reported 4 times negative net income.
GKO had a negative operating cash flow in each of the past 5 years.
GKO.CA Yearly Net Income VS EBIT VS OCF VS FCFGKO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M

1.2 Ratios

Industry RankSector Rank
ROA -99.34%
ROE -303.02%
ROIC N/A
ROA(3y)-41.37%
ROA(5y)-73.89%
ROE(3y)-151.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GKO.CA Yearly ROA, ROE, ROICGKO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GKO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GKO.CA Yearly Profit, Operating, Gross MarginsGKO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

GKO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GKO has more shares outstanding
Compared to 5 years ago, GKO has more shares outstanding
GKO has a worse debt/assets ratio than last year.
GKO.CA Yearly Shares OutstandingGKO.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
GKO.CA Yearly Total Debt VS Total AssetsGKO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

GKO has an Altman-Z score of -4.37. This is a bad value and indicates that GKO is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 1.21 is on the high side and indicates that GKO has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z -4.37
ROIC/WACCN/A
WACC6.91%
GKO.CA Yearly LT Debt VS Equity VS FCFGKO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

A Current Ratio of 0.33 indicates that GKO may have some problems paying its short term obligations.
GKO has a Quick Ratio of 0.33. This is a bad value and indicates that GKO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
GKO.CA Yearly Current Assets VS Current LiabilitesGKO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

0

3. Growth

3.1 Past

The earnings per share for GKO have decreased strongly by -98.43% in the last year.
Looking at the last year, GKO shows a very negative growth in Revenue. The Revenue has decreased by -61.77% in the last year.
EPS 1Y (TTM)-98.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.92%
Revenue 1Y (TTM)-61.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GKO.CA Yearly Revenue VS EstimatesGKO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 20K 40K 60K 80K 100K
GKO.CA Yearly EPS VS EstimatesGKO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GKO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GKO.CA Price Earnings VS Forward Price EarningsGKO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GKO.CA Per share dataGKO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GKO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GEEKCO TECHNOLOGIES CORP

TSX-V:GKO (3/7/2025, 7:00:00 PM)

0.035

-0.02 (-36.36%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-06 2024-12-06
Earnings (Next)04-29 2025-04-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.97%
Ins Owner ChangeN/A
Market Cap2.54M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 94.66
P/FCF N/A
P/OCF N/A
P/B 1.93
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.02
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -99.34%
ROE -303.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41.37%
ROA(5y)-73.89%
ROE(3y)-151.27%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -4.37
F-ScoreN/A
WACC6.91%
ROIC/WACCN/A
Cap/Depr(3y)110.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)467.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-85.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.44%
OCF growth 3YN/A
OCF growth 5YN/A